5/20/11 Contest Update
Perhaps it was a sign Wall Street is not ready for the “Rapture.” In any case, the prayers of most investors went unanswered for another week. Biotechs, however, held up better than most, no doubt meaning the sinners in our midst are few in number.
At Friday’s close, the Nasdaq Biotech Index was up 15.84% YTD (vs. up 16.65% YTD a week ago) and the Contest median was up 11.64% YTD (vs. up 11.81% YTD a week ago). The Nasdaq Composite Index was up 5.67% YTD (vs. up 6.62% YTD a week ago).
MCBIO’s portfolio (up 41.36% YTD) maintained a lock on first place, with CRAZYP’s portfolio (up 34.61% YTD) and ROCKY’s portfolio (up 31.98% YTD) holding on to second and third place..
At Friday's close, 32 of the 38 Contest portfolios were in the black with 14 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a wonderful weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
5/20/11
Rank Name Profit/Loss
1 MCBIO 41,363
2 CRAZYP 34,612
3 ROCKY 31,978
4 FIB 30,152
5 RRGE 29,425
6 IJF 29,036
7 RKRW 25,790
8 GENE 23,426
9 GHMM 21,438
10 IMAN 20,372
Week's Top 5 Gainers
Symbol 5/13 5/20 % change
ACOR 26.05 30.38 16.62%
SPPI 7.58 8.66 14.25%
ANTH 7.29 8.17 12.07%
CADX 7.72 8.61 11.53%
VVUS 7.98 8.81 10.47%
Week's Top 5 Losers
Symbol 5/13 5/20 % change
MRNA 0.45 0.25 -43.82%
TLON.OB 1.28 1.00 -21.88%
AEGR 21.85 17.52 -19.82%
MSHL 1.47 1.25 -14.93%
OMER 5.01 4.33 -13.57% |
